News
16d
GlobalData on MSNGSK’s speciality medicines soar while generals drop, Q2 results reveal
UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its current portfolio. While the company’s total sales in this period totalled £8bn ...
2d
MONTCO Today on MSNWSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine Dispute
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...
1d
TipRanks on MSNGSK Expands Share Buyback Programme with New Purchase
GlaxoSmithKline has announced the purchase of 306,478 of its own ordinary shares as part of its ongoing buyback programme. This transaction, executed through Merrill Lynch International, is part of a ...
Indian drugmaker GlaxoSmithKline Pharma reported its first quarterly revenue decline in more than two years on Friday, ...
A month has gone by since the last earnings report for GSK (GSK). Shares have added about 3.2% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up ...
LONDON—With its second-quarter report Wednesday, GlaxoSmithKline PLC GSK -1.52% has pivoted investors toward future expansion following its $20 billion asset swap with Novartis AG, saying it is ...
Jan 15 (Reuters) - GlaxoSmithKline (GSK.L) on Saturday said it had rejected a 50-billion-pound offer from Unilever (ULVR.L) for its consumer goods arm, saying it "fundamentally undervalued" the ...
After its own COVID-19 vaccine setback, GlaxoSmithKline has inked a $180 million deal to help German biotech company CureVac manufacture 100 million doses of its mRNA vaccine, which is currently ...
Swiss scientist convicted for conspiring to steal GSK trade secrets GlaxoSmithKline to buy California biotech firm for $1.9B Venatorx lands financing; Ocugen clinical trial takes 'critical' step ...
GlaxoSmithKline PLC leaders and executives have shown their dedication by being a leading pharmaceutical company and research and development firm. GSK was named one of the 100 Best Companies for ...
Avandia: GlaxoSmithKline Cover-Up Turns Off Doctors GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. By ABC News July 13, 2010, 11:24 AM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results